MGRX vs WAB · rev $456.0K vs P/E 38, rev $3.18B
Mangoceuticals, Inc. Common Stock (MGRX) versus Westinghouse Air Brake Technologies Corp (WAB) — a side-by-side from cached financials, not a winner call.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
Westinghouse Air Brake Technologies Corp (WAB) is a railroads company listed on NYSE.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
Latest reported WAB revenue for 2026-06-30 was $3.18B. Net income was $395.0M. Revenue was up 7.8% from 2026-03-31 to 2026-06-30. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
MGRX currently screens at market cap $16.3M. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
Not investment advice. Open the MGRX and WAB stock pages for the full models.
Not investment advice.